Diagnosis and management of gestational diabetes mellitus

American Family Physician

Volumn 80, Issue 1, 2009, Pages 57-62

  Serlin, David C ^a   Lash, Robert W ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; METFORMIN;

AMNION FLUID; CESAREAN SECTION; CLINICAL TRIAL; EXERCISE; FETAL WELL BEING; FRACTURE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; INTRAPARTUM CARE; LABOR INDUCTION; LIFESTYLE MODIFICATION; NERVE PARALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL SUPPORT; ORAL GLUCOSE TOLERANCE TEST; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PRENATAL CARE; PUERPERIUM; REVIEW; SCREENING TEST; SHOULDER DYSTOCIA; THIRD TRIMESTER PREGNANCY;

EID: 67650446335     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Brody SC, Harris R, Lohr K. Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol. 2003;101(2):380-392.
2. Tuffnell DJ, West J, Walkinshaw SA. Treatments for gestational diabetes and impaired glucose tolerance in pregnancy. Cochrane Database Syst Rev. 2003;(3):CD003395.
3. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, for the Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477-2486.
4. U.S. Preventive Services Task Force. Screening for gestational diabetes. Topic page. Rockville, Md: Agency for Healthcare Research and Quality; 2008. http://www.ahrq.gov/clinic/uspstf/uspsgdm.htm. Accessed January 5, 2009.
5. Metzger BE, Lowe LP, Dyer AR, for the HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991-2002.
6. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstretrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol. 2001;98(3):525-538.
7. Naylor CD, Sermer M, Chen E, Farine D. Selective screening for gestational diabetes mellitus. Toronto Trihospital Gestational Diabetes Project Investigators. N Engl J Med. 1997;337(22):1591-1596.
8. Cosson E, Benchimol M, Carbillon L, et al. Universal rather than selective screening for gestational diabetes mellitus may improve fetal outcomes. Diabetes Metab. 2006;32(2):140-146.
9. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care. 1998;21(suppl 2):B161-B167.
10. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus [published correction appears in Diabetes Care. 2007;30(12):3154]. Diabetes Care. 2007;30(suppl 2):S251-S260.
11. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2004;27(suppl 1):S88-S90.
12. Agarwal MM, Dhatt GS, Punnose J, Zayed R. Gestational diabetes: fasting and postprandial glucose as first prenatal screening tests in a highrisk population. J Reprod Med. 2007;52(4):299-305.
13. Buhling KJ, Elsner E, Wolf C, et al. No influence of high- and lowcarbohydrate diet on the oral glucose tolerance test in pregnancy. Clin Biochem. 2004;37(4):323-327.
14. Hollander MH, Paarlberg KM, Huisjes AJ. Gestational diabetes: a review of the current literature and guidelines. Obstet Gynecol Surv. 2007; 62(2):125-136.
15. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768-773.
16. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553.
17. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2003;26(suppl 1):S103-S105.
18. Pennison EH, Egerman RS. Perinatal outcomes in gestational diabetes: a comparison of criteria for diagnosis. Am J Obstet Gynecol. 2001; 184(6):1118-1121.
19. Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O. Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. Am J Obstet Gynecol. 2004;191(3):949-953.
20. Parretti E, Mecacci F, Papini M, et al. Third-trimester maternal glucose levels from diurnal profiles in nondiabetic pregnancies: correlation with sonographic parameters of fetal growth. Diabetes Care. 2001; 24(8):1319-1323.
21. de Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med. 1995;333(19):1237-1241.
22. Jovanovic L, Ilic S, Pettitt DJ, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care. 1999;22(9):1422-1427.
23. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134-1138.
24. Jacobson GF, Ramos GA, Ching JY, Kirby RS, Ferrara A, Field DR. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol. 2005;193(1):118-124.
25. Moore TR. Glyburide for the treatment of gestational diabetes [published correction appears in Diabetes Care. 2007;30(12):3154]. Diabetes Care. 2007;30(suppl 2):S209-S213.
26. Elliott BD, Langer O, Schenker S, Johnson RF. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol. 1991;165(4 pt 1):807-812.
27. Hebert MF, Naraharisetti SB, Ma X, et al. Are we guessing glyburide dosage in the treatment of gestational diabetes (GDM)? The pharmacological evidence for better clinical practice. Am J Obstet Gynecol. 2007;197(6):S25.
28. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes [published correction appears in N Engl J Med. 2008;359(1):106]. N Engl J Med. 2008;358(19):2003-2015.
29. Kjos SL, Leung A, Henry OA, Victor MR, Paul RH, Medearis AL. Antepartum surveillance in diabetic pregnancies: predictors of fetal distress in labor. Am J Obstet Gynecol. 1995;173(5):1532-1539.
30. Caplan RH, Pagliara AS, Beguin EA, et al. Constant intravenous insulin infusion during labor and delivery in diabetes mellitus. Diabetes Care. 1982;5(1):6-10.
31. Boulvain M, Stan C, Irion O. Elective delivery in diabetic pregnant women. Cochrane Database Syst Rev. 2001;(2):CD001997.
32. Rouse DJ, Owen J, Goldenberg RL, Cliver SP. The effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound. JAMA. 1996;276(18):1480-1486.
33. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10): 1862-1868.
34. Kim C, Herman WH, Vijan S. Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care. 2007;30(5):1102-1106.
35. Knowler WC, Barrett-Connor E, Fowler SE, for the Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403.